Comment from Anil Achyuta, TDK Ventures, and YP Huang, Applied Ventures

Spatial transcriptomics is an emerging technique that allows researchers not only know when a gene is turned on, but also helps in determining where it is turned on in an intact tissue, which researchers call “their dream”. The acquisition of Spatial Transcriptomics, ReadCoor, and Cartana recently shows the interest by larger companies to accelerate their innovations in this space.

The living cell is one of the most complex machinery known to mankind. At any point in time, there are millions of computations happening concurrently, to either turn a gene on or off to make a protein, to accelerate or slowdown chemical reactions, to increase energy consumption or not, to let a particle in or not, to balance the pH between the interior and exterior portions of the cell and so on. One can imagine these dynamic interactions within the cell to be akin to listening to Beethoven’s symphonies. While the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?